Welcome : Guest

VETERINARY VACCINES - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for Veterinary Vaccines in US$ by the following Product Segments: Companion Animal Vaccines (Canine Vaccines, & Feline Vaccines), and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines, & Other Animal Vaccines). The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 102 companies including many key and niche players such as -

Bayer HealthCare AG
Biogénesis Bagó
Boehringer Ingelheim GmbH
Ceva Santé Animale
Elanco Animal Health

Click here to request a full list of companies covered in the report...

Code: MCP-1129
Price: $4950
Companies: 102
Pages: 306
Date: May 2016
Market Data Tables: 88
 



TABLE OF CONTENTS


  VETERINARY VACCINES (Complete Report) Pages : 306   | $4950

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Product Definitions and Scope of Study.....I-3  
   Market Outlook.....II-11$100
   Convergence of Factors Prime the Market for Sizable Growth.....II-2
Sizing the Global Veterinary Vaccines Market.....II-2
1$100
   Table 1: Global Animal Health Products Market by Region (2015): Percentage Share Breakdown by Value Sales for Asia-Pacific, Europe, Latin America, North America and Rest of World (includes corresponding Graph/Chart).....II-3

Table 2: Global Animal Health Products Market by Product Group (2015): Percentage Breakdown by Value Sales for Anti-Infectives, Medicinal Feed Additives, Parasiticides, Vaccines and Other Pharmaceuticals (includes corresponding Graph/Chart).....II-3
1$350
   Mature Markets Vis-a-vis Emerging Markets.....II-4
Veterinary Vaccines – A Highly Consolidated Market.....II-4
1$100
   Scientific R&D – Crucial for Market Growth.....II-5
Market Challenges.....II-5
1$100
   Need to Ensure Sustainable Food Supply Spurs Growth.....II-6
Increasing Demand for Animal Protein in Developing Countries to Benefit the
  Market.....II-6
1$100
   Table 3: Projected Global Per Capita Consumption of Meat (in kg per year) by Geographic Region by the year 2030 (includes corresponding Graph/Chart).....II-7

Table 4: Projected Global Consumption of Animal Products (in million tons) by Developing and Developed Countries for the year 2030 (includes corresponding Graph/Chart).....II-7
1$350
   Growing Momentum for Post Slaughter Strategies Bodes well for Animal Medicine.....II-8
Management of Emerging Diseases – A Case of Development and Demand Novel
  Vaccines.....II-8
Need to Safeguard Public Health Drives Interest in Veterinary Vaccines.....II-8
Social Concerns on Slaughtering Presents a Valid Case for Use of Vaccines.....II-8
1$100
   Companion Animals: A Lucrative Market Segment.....II-9
Increasing Pet Ownership Drives Demand for Companion Animal Vaccines.....II-9
1$100
   Table 5: World Pet Dog Ownership (2016E): Top Ten Nations with Dog Population in Millions (includes corresponding Graph/Chart).....II-10

Table 6: World Pet Cat Ownership (2016E): Top Ten Nations with Cat Population in Millions (includes corresponding Graph/Chart).....II-10
1$350
   Spread of Zoonotic Diseases Propels Growth.....II-11
Porcine Market Offers Significant Prospects for Growth and New Vaccine
  Development.....II-11
1$100
   Select Key Marketed Porcine Reproductive and Respiratory Syndrome (PRRS)
  Vaccines.....II-12
1$100
   Porcine Epidemic Diarrhea Virus (PEDV) Vaccines Available in Select Countries.....II-13
Recombinant DNA Technology to Take Over the Industry.....II-13
1$100
   Improvised Adjuvant Usage and Veterinary Vaccine Delivery Systems.....II-141$100
   New Effervescent Tablets Vaccines against NDV – Augmenting Trend towards Convenient
  Administration.....II-15
1$100
   One-Shot Vaccine against BVD - New Innovation Promises to Change Vaccination
  Paradigm.....II-16
Anthrax, Rabies, and Other Vaccines with Improved Adjuvants in the Pipeline.....II-16
Global Efforts to Conquer FMD by an Effective Vaccine.....II-16
1$100
   Developments in the Poultry Vaccine Market.....II-171$100
   Vaccination – Critical for Controlling Avian Influenza Virus.....II-18
Parasitic Vaccines Segment Holds Potential.....II-18
1$100
   Egg-Derived Veterinary Vaccines in Human Vaccine Facilities.....II-19
New Vaccines Strains – The Imminent Need in the Vaccine Market.....II-19
The Need for Innovative Vaccine Delivery Mechanism Increasing.....II-19
More Vaccines Needed to Prevent Zoonotic Infections.....II-19
1$100
   Plant-based Vaccines – the Next Avenue in Cost-effective and Efficacious Vaccines;
  Obstacles Persist Delaying Market Debut.....II-20
1$100
   Pricing Affects the Livestock Vaccine Market.....II-21
Over-Vaccination Trend May Prove Harmful.....II-21
1$100
   Vaccines – An Evolutionary Scan.....II-22
Veterinary Medicines – A Brief Review.....II-22
1$100
   Concept Development.....II-23
Production of Vaccines.....II-23
1$100
   Veterinary Vaccines – An Essential Component of Animal Healthcare.....II-24
What Does A Veterinary Vaccine Do?.....II-24
Classification of Veterinary Vaccines.....II-24
Companion Animal Vaccines.....II-24
1$100
   Canine Vaccines.....II-251$100
   Canine Distemper.....II-26
Canine Parvovirus.....II-26
Tracheobronchitis.....II-26
Canine Coronavirus.....II-26
Canine Leptospirosis.....II-26
Canine Giardia.....II-26
Canine Lyme borreliosis.....II-26
Canine Rabies.....II-26
1$100
   Feline Vaccines.....II-27
Feline Panleukopenia Virus Vaccine.....II-27
Feline Calicivirus & Herpesvirus Vaccine.....II-27
Rabies Virus Vaccine.....II-27
Feline Leukemia Virus Vaccine.....II-27
1$100
   Chlamydia, Feline Infectious Peritonitis, and Ringworm Vaccines.....II-28
Livestock Vaccines.....II-28
Bovine Vaccines.....II-28
Bovine virus diarrhoea – Mucosal disease (BVD-MD).....II-28
Johne's disease.....II-28
Infectious Bovine Rhinotracheitis (IBR).....II-28
Blackleg.....II-28
1$100
   Neosporosis.....II-29
Poultry Vaccines.....II-29
Ovine Vaccines.....II-29
Porcine Vaccines.....II-29
1$100
   Equine Vaccines.....II-30
Aquaculture Vaccines.....II-30
A Tabular Analysis on Select Animal Diseases Controlled by Vaccines.....II-30
Vaccination and Its Reactions.....II-30
1$100
   Veterinary Vaccines – Latest Breakthroughs.....II-31
Marker/DIVA Vaccines.....II-31
DNA Vaccines.....II-31
Gene-Deleted Vaccines.....II-31
Viral-Vectored Vaccines.....II-31
1$100
   Brucellosis.....II-32
Tuberculosis.....II-32
Johne’s disease.....II-32
Spirochete Associated Diseases.....II-32
Respiratory Disease in Goats, Sheep, and Cattle.....II-32
1$100
   Porcine Respiratory Diseases.....II-33
Mastitis.....II-33
African Swine Fever.....II-33
Avian Influenza.....II-33
East Coast Fever.....II-33
1$100
   Hemorrhagic Septicemia.....II-34
Foot-And-Mouth Disease.....II-34
Japanese Encephalitis.....II-34
Rift Valley Fever.....II-34
Equine Virus Infection.....II-34
1$100
   MSD Animal Health Unveils PORCILIS PCV ID.....II-35
Virbac Rolls Out Lepto4 Vaccine.....II-35
Merck Animal Health Rolls Introduces Vaccine against New H3N2 Strain.....II-35
Zoetis Launches First USDA-Approved Equine Leptospirosis Vaccine, Lepto EQ.....II-35
Ceva Introduces New Porcine Pneumonia Vaccine.....II-35
Boehringer Ingelheim Rolls Out Two New PRRS Swine Vaccines in Europe.....II-35
MSD Animal Health Launches INNOVAX®-ILT.....II-35
1$100
   Zoetis UK Unveils New Versican® Plus Canine Vaccine Range.....II-36
Indian Immunologicals to Launch Procine Cysticercosis Vaccine.....II-36
MSD Animal Health Rolls Out Single-Injection Vaccine for Salmon.....II-36
Merck Animal Health Launches PORCILIS® PCV M Hyo Single-Injection Vaccine for
  Piglets.....II-36
Prevtec Microbia Obtains EU Clearance for Coliprotec F4 Vaccine.....II-36
Hester Biosciences Rolls Out Two New Vaccines.....II-36
Boehringer Ingelheim Vetmedica Launches Bovela® BVD Vaccine.....II-36
Immunologicals Launches First Vaccine against Bluetongue Disease in India.....II-36
1$100
   Boehringer Ingelheim Secures EU Clearance for BVD Vaccine Bovela®.....II-37
Merck Animal Health Rolls Out PRIME PAC PRRS+ Porcine Vaccine.....II-37
Larad to Sell Poultry IBD Vaccine.....II-37
AgriLabs Introduces Autogenous Klebsiella Mastitis Vaccine.....II-37
Boehringer Ingelheim Vetmedica Introduces ULTRA™ Fel-O-Vax® Vaccine for Cats.....II-37
Boehringer Ingelheim Vetmedica Introduces New Vaccine for Respiratory Diseases in
  Pigs.....II-37
Valneva Launches Second Vaccine in EB66® Cell Line in South America.....II-37
Merck Animal Health Launches Combination Vaccine with Longer Immunity Duration for
  Pigs.....II-37
1$100
   Bayer Teams Up with BioNTech for Development of Innovative Veterinary mRNA
  Vaccines.....II-38
Harrisvaccines Secures Production Platform Vaccine Licensure from USDA.....II-38
Orix to Acquire Kyoto Biken.....II-38
Phibro to Take Over Vaccine Assets of MVP Laboratories.....II-38
Sumitomo Acquires Stake in Shandong Sinder Technology.....II-38
Sanofi and Boehringer Ingelheim Ink Deal to Swap Business.....II-38
1$100
   Merck Animal Health Inks Deal to Take Over Harrisvaccines.....II-39
Zoetis to Take Over PHARMAQ.....II-39
VitamFero and Bioproperties Execute Co-development and Distribution Deal for
  Toxoplasmosis Vaccine.....II-39
Dechra to Buy Chicken Vaccine Maker Genera.....II-39
Valneva Licenses EB66(r) Cell Line for Vaccines to Jianshun Biosciences for
  China.....II-39
Eli Lilly Acquires Novartis Animal Health through Elanco.....II-39
Biogénesis Bagó Begins Construction of New Vaccine Plant in China.....II-39
1$100
   Inovio Pharmaceuticals’s Subsidiary Divests Animal Health Assets.....II-40
Braasch Biotech Receives Patent Acceptance in Europe for JH14-Somatovac®
  Vaccine.....II-40
Elanco Inks Agreement to Take Over Lohmann.....II-40
1$100
   Bayer HealthCare AG (Germany).....II-41
Biogénesis Bagó (Argentina).....II-41
1$100
   Boehringer Ingelheim GmbH (Germany).....II-42
Ceva Santé Animale (France).....II-42
1$100
   Elanco Animal Health (US).....II-43
Heska Corporation (US).....II-43
1$100
   Indian Immunologicals Ltd. (India).....II-44
Merck Animal Health (US).....II-44
Merial Ltd. (US).....II-44
1$100
   Virbac SA (France).....II-45
Zoetis Inc. (US).....II-45
2$200
   Table 7: World Recent Past, Current & Future Analysis for Veterinary Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-471$350
   Table 8: World Historic Review for Veterinary Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-481$350
   Table 9: World 14-Year Perspective for Veterinary Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....II-491$350
   Table 10: World Recent Past, Current & Future Analysis for Companion Animal Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-501$350
   Table 11: World Historic Review for Companion Animal Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-511$350
   Table 12: World 14-Year Perspective for Companion Animal Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....II-521$350
   Table 13: World Recent Past, Current & Future Analysis for Companion Animal Vaccines by Product Segment - Canine Vaccines and Feline Vaccines Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-531$350
   Table 14: World Historic Review for Companion Animal Vaccines by Product Segment - Canine Vaccines and Feline Vaccines Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-541$350
   Table 15: World 14-Year Perspective for Companion Animal Vaccines by Product Segment - Percentage Breakdown of Dollar Sales for Canine Vaccines and Feline Vaccines Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....II-551$350
   Table 16: World Recent Past, Current & Future Analysis for Canine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-561$350
   Table 17: World Historic Review for Canine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-571$350
   Table 18: World 14-Year Perspective for Canine Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....II-581$350
   Table 19: World Recent Past, Current & Future Analysis for Feline Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-591$350
   Table 20: World Historic Review for Feline Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-601$350
   Table 21: World 14-Year Perspective for Feline Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....II-611$350
   Table 22: World Recent Past, Current & Future Analysis for Livestock Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-621$350
   Table 23: World Historic Review for Livestock Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-631$350
   Table 24: World 14-Year Perspective for Livestock Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....II-641$350
   Table 25: World Recent Past, Current & Future Analysis for Livestock Vaccines by Product Segment - Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-651$350
   Table 26: World Historic Review for Livestock Vaccines by Product Segment - Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-661$350
   Table 27: World 14-Year Perspective for Livestock Vaccines by Product Segment - Percentage Breakdown of Dollar Sales for Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....II-671$350
   Table 28: World Recent Past, Current & Future Analysis for Porcine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-681$350
   Table 29: World Historic Review for Porcine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-691$350
   Table 30: World 14-Year Perspective for Porcine Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....II-701$350
   Table 31: World Recent Past, Current & Future Analysis for Bovine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-711$350
   Table 32: World Historic Review for Bovine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-721$350
   Table 33: World 14-Year Perspective for Bovine Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....II-731$350
   Table 34: World Recent Past, Current & Future Analysis for Poultry Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-741$350
   Table 35: World Historic Review for Poultry Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-751$350
   Table 36: World 14-Year Perspective for Poultry Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....II-761$350
   Table 37: World Recent Past, Current & Future Analysis for Ovine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-771$350
   Table 38: World Historic Review for Ovine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-781$350
   Table 39: World 14-Year Perspective for Ovine Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....II-791$350
   Table 40: World Recent Past, Current & Future Analysis for Equine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-801$350
   Table 41: World Historic Review for Equine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-811$350
   Table 42: World 14-Year Perspective for Equine Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....II-821$350
   Table 43: World Recent Past, Current & Future Analysis for Other Animal Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-831$350
   Table 44: World Historic Review for Other Animal Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-841$350
   Table 45: World 14-Year Perspective for Other Animal Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....II-851$350
   A. Market Analysis.....III-1
Food Safety Concerns and Biotechnological Offerings Drive the Veterinary Vaccines
  Market.....III-1
Dogs and Cats Obesity Vaccines Receive First US Patent.....III-1
1$75
   H5N1 Virus: A Conundrum for the US Industry.....III-2
Product Approvals/Launches.....III-2
1$75
   Strategic Corporate Developments.....III-31$75
   Select Major Players.....III-43$225
   B. Market Analytics.....III-7
Table 46: The US Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-7
1$200
   Table 47: The US Historic Review for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-81$200
   Table 48: The US 14-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-91$200
   A. Market Analysis.....III-10
Steady Market Growth Expected Due to Superior Livestock Management.....III-10
Regulations.....III-10
1$75
   EU Animal Welfare Strategy.....III-11
Product Approvals/Launches.....III-11
Strategic Corporate Developments.....III-11
1$75
   B. Market Analytics.....III-12
Table 49: European Recent Past, Current & Future Analysis for Veterinary Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-12
1$200
   Table 50: European Historic Review for Veterinary Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-131$200
   Table 51: European 14-Year Perspective for Veterinary Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, and Rest of Europe Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-141$200
   Table 52: European Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-151$200
   Table 53: European Historic Review for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-161$200
   Table 54: European 14-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-171$200
   A. Market Analysis.....III-18
Current & Future Analysis.....III-18
Product Launches.....III-18
Select Major Players.....III-18
2$150
   B. Market Analytics.....III-20
Table 55: French Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines and Equine Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-20
1$200
   Table 56: French Historic Review for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines and Equine Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-211$200
   Table 57: French 14-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines and Equine Vaccines) Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-221$200
   A. Market Analysis.....III-23
Current & Future Analysis.....III-23
Product Launches.....III-23
Strategic Corporate Developments.....III-23
1$75
   Select Major Players.....III-242$150
   B. Market Analytics.....III-26
Table 58: German Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines and Equine Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-26
1$200
   Table 59: German Historic Review for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines and Equine Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-271$200
   Table 60: German 14-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines and Equine Vaccines) Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-281$200
   Market Analysis.....III-29
Market Analysis.....III-29
1$75
   Table 61: Italian Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-301$200
   Table 62: Italian Historic Review for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-311$200
   Table 63: Italian 14-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-321$200
   A. Market Analysis.....III-33
Current & Future Analysis.....III-33
Product Launches.....III-33
1$75
   B. Market Analytics.....III-34
Table 64: The UK Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-34
1$200
   Table 65: The UK Historic Review for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-351$200
   Table 66: The UK 14-Year Perspective for Veterinary Vaccines by Product Group/ Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-361$200
   Market Analysis.....III-37
Market Analysis.....III-37
1$75
   Table 67: Spanish Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-381$200
   Table 68: Spanish Historic Review for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-391$200
   Table 69: Spanish 14-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-401$200
   A. Market Analysis.....III-41
Current & Future Analysis.....III-41
A Review of Select Regional Markets.....III-41
The Netherlands.....III-41
Denmark.....III-41
2$150
   Russia Mass-Produces Vaccines Against Avian Flu.....III-43
Product Launch.....III-43
Strategic Corporate Development.....III-43
1$75
   B. Market Analytics.....III-44
Table 70: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-44
1$200
   Table 71: Rest of Europe Historic Review for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-451$200
   Table 72: Rest of Europe 14-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-461$200
   A. Market Analysis.....III-47
Current & Future Analysis.....III-47
Focus on Select Markets.....III-47
Asia-Pacific.....III-47
1$75
   Table 73: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Vaccines by Region - China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-481$200
   Table 74: Asia-Pacific Historic Review for Veterinary Vaccines by Region - China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-491$200
   Table 75: Asia-Pacific 14-Year Perspective for Veterinary Vaccines by Region - Percentage Breakdown of Dollar Sales for China and Rest of Asia-Pacific Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-501$200
   China.....III-51
Increased Livestock Output and Emerging Pet Industry Lead to Higher Vaccine
  Demand.....III-51
1$75
   Table 76: Chinese Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Segment - Porcine Vaccines, Poultry Vaccines, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-521$200
   Table 77: Chinese Historic Review for Veterinary Vaccines by Product Segment - Porcine Vaccines, Poultry Vaccines, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-531$200
   Table 78: Chinese 14-Year Perspective for Veterinary Vaccines by Product Segment - Percentage Breakdown of Dollar Sales for Porcine Vaccines, Poultry Vaccines, and Other Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-54
Growing Pet Industry Holds Promise.....III-54
Threat of Avian Influenza Outbreaks Creates Market for Effective Vaccine.....III-54
1$200
   Demand for Higher-Quality Swine Fever Vaccine.....III-55
Demand for Effective PRRS Vaccines by Foreign Manufacturers.....III-55
FMD Epidemics Cause Increased demand for Vaccine.....III-55
1$75
   Effective Rabies Vaccine Needed to Curb Dog Menace.....III-56
Highly Consolidated Chinese Veterinary Market.....III-56
1$75
   Rest of Asia-Pacific.....III-57
India.....III-57
Animal Vaccines Market to Surge.....III-57
Table 79: Indian Animal Health Products Market by Segment (2015): Percentage Breakdown of Value Sales for Feed Supplements, Therapeutics and Vaccines (includes corresponding Graph/Chart).....III-57
Major Players.....III-57
1$200
   New Opportunities Exist despite Well Established Market.....III-58
Table 80: Indian Veterinary Vaccines Market by Segment (2015): Percentage Breakdown of Value Sales for Companion Animals, Livestock and Poultry (includes corresponding Graph/Chart).....III-58
1$200
   North Korea.....III-59
Taiwan.....III-59
Taiwan’s Animal Healthcare Industry under Scan.....III-59
Australia.....III-59
A Note on Australian Veterinary Therapeutics Market.....III-59
Sizing the Market.....III-59
1$75
   Table 81: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Vaccines Market Analyzed in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-601$200
   Table 82: Rest of Asia-Pacific Historic Review for Veterinary Vaccines Market Analyzed in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-611$200
   Latin America.....III-62
Current & Future Analysis.....III-62
Table 83: Latin American Recent Past, Current & Future Analysis for Veterinary Vaccines by Region - Brazil and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-62
1$200
   Table 84: Latin American Historic Review for Veterinary Vaccines by Region - Brazil and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-631$200
   Table 85: Latin American 14-Year Perspective for Veterinary Vaccines by Region - Percentage Breakdown of Dollar Sales for Brazil and Rest of Latin America Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-641$200
   Canada.....III-65
Overview of the Canadian Animal Health Industry.....III-65
Imports and Manufacture of Veterinary Biologics.....III-65
First to Access E. coli 0157:H7 Vaccine.....III-65
Product Launches.....III-65
1$75
   Strategic Corporate Developments.....III-661$75
   Key Players.....III-671$75
   B. Market Analytics.....III-68
Table 86: Rest of World Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-68
1$200
   Table 87: Rest of World Historic Review for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-691$200
   Table 88: Rest of World 14-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-701$200
  
Total Companies Profiled: 102 (including Divisions/Subsidiaries - 123)

Region/Country Players

The United States 23 Canada 2 Japan 6 Europe 41 France 7 Germany 7 The United Kingdom 6 Italy 3 Spain 4 Rest of Europe 14 Asia-Pacific (Excluding Japan) 33 Latin America 10 Middle-East 3 Africa 5
Click here to request a full table of contents and more details on this project.